Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received October 23, 2018
- Accepted in final form April 22, 2019
- First Published August 12, 2019.
Article Versions
- Previous version (August 12, 2019 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Divyanshu Dubey, MD,
- William S. David, MD, PhD,
- Anthony A. Amato, MD,
- Kerry L. Reynolds, MD,
- Nathan F. Clement, MD,
- Donald F. Chute,
- Justine V. Cohen, DO,
- Donald P. Lawrence, MD,
- Meghan J. Mooradian, MD,
- Ryan J. Sullivan, MD and
- Amanda C. Guidon, MD
- Divyanshu Dubey, MD,
NONE
NONE
NONE
Journal of Clinical Medicine, editorial board, 2019
KLHL11 as markers of neurological autoimmunity.
NONE
NONE
(1) UCB pharmaceuticals. All compensation for consulting activities is paid directly to Mayo Clinic.
NONE
NONE
NONE
(1) Grifols pharmaceuticals
NONE
(1) Center of Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- William S. David, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Anthony A. Amato, MD,
Medical Advisory Board for Alexion,Novartis,DART,Biogen, Acceleron
NONE
NONE
Associate Editor for Neurology
NONE
Amato AA, Russell J. Neuromuscular Disease (2nd Ed). New York: McGraw-Hill, 2016
NONE
Medical Consultant for Biogen, Alexion,Novartis, Acceleron, Up-to-Date, and Best Doctors
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Expert witness for defendant in medical malpractice cases
- Kerry L. Reynolds, MD,
NONE
NONE
NONE
NONE
NONE
NONE
Teladoc, Case Manager, 8 years Stock/Stock Options, Medical Equipment & Materials: Husband, Biogen, 1 yr
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Nathan F. Clement, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
I am currently on active duty in the United States Air Force (USAF). The USAF did not sponsor me nor provide funding for this research project. My participation in this project was as a volunteer.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Donald F. Chute,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Justine V. Cohen, DO,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Sanofi-Genzyme
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Donald P. Lawrence, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Meghan J. Mooradian, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ryan J. Sullivan, MD and
Bristol-Myers-Squib (unpaid), Merck (compensated), Syndax (compensated), Replimmune (compensated), Compugen (compensated), Array (compensated), Novartis (compensated)
NONE
Genentech, Novartis
Associate editor for Current Oncology Reports (uncompensated), Associate editor for Cancer.net.
NONE
Up-to-Date
NONE
see above for SABs
NONE
NONE
NONE
Amgen, Merck
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Amanda C. Guidon, MD
(1) Alexion
NONE
(1) RaPharma (travel to investigator meeting) (2) PCORI (travel to investigator meeting) (3) Momenta Pharmaceuticals (travel to investigator meeting)
NONE
NONE
(1) Comprehensive Review of Neuromuscular and Electrodiagnostic Medicine, The Oakstone Institute, 2014, 2016 and 2018.
NONE
(1) Momenta Pharmaceuticals
NONE
1) Speaker honoraria (Massachusetts Neurologic Association) - CME activity
NONE
(1) RaPharma - Clinical trial (2) Momenta Pharmaceuticals - Clinical trial (3) Spouse employed by GE Healthcare
1) PCORI - PROMISE MG Study - Site PI Stock/Stock Options, Medical Equipment & Materials: Spouse owns General Electric (GE) stock, 2013 - present
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Departments of Neurology (D.D., W.S.D., A.C.G.), Medicine (K.L.R., D.F.C., J.V.C., D.P.L., M.J.M., R.J.S.), and Pathology (N.F.C.), Massachusetts General Hospital; Department of Neurology (D.D., A.A.A.), Brigham and Women's Hospital, Boston, MA; and Department of Neurology (D.D.), Mayo Clinic, Rochester, MN.
- Correspondence
Dr. Guidon aguidon{at}mgh.harvard.edu
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.